15Jan/14

Cincinnati Children's creates lung transplant program – Cincinnati.com

Cincinnati Children’s creates lung transplant program
Cincinnati.com
Cincinnati Children’s Hospital Medical Center has started a pediatric lung transplant program. The hospital will be one of the few in the country capable of performing transplants for infants as small as 11 pounds, hospital officials said. The program
Cincinnati Children’s Launches Lung Transplant ProgramSYS-CON Media (press release)

all 6 news articles »

15Jan/14

Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Teva Pharmaceutical … – Seeking Alpha

Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Teva Pharmaceutical
Seeking Alpha
Treanda, used for the treatment of patients with chronic lymphocytic leukemia (CLL) and patients with indolent B-cell non-Hodgkin’s lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing

and more »

15Jan/14

Organ donor Bill: Jo-Anne Dobson pressing for a new law for over a year – but … – Belfast Telegraph


Belfast Telegraph

Organ donor Bill: Jo-Anne Dobson pressing for a new law for over a year – but
Belfast Telegraph
Mr Ross, a member of the All Party Group on Organ Donation, said he agreed on many issues with Ms Dobson but not the new system, which he described as “presumed consent”. “There is one fundamental issue that we disagree on, namely a move towards 
‘Confusion’ over organ donation as MLAs table rival billsBelfast Newsletter

all 3 news articles »

15Jan/14

FDA sets standard review for Gilead's idelalisib in NHL – PMLiVE

FDA sets standard review for Gilead’s idelalisib in NHL
PMLiVE
The marketing application in NHL was filed last September on the back of a single phase II trial in patients whose disease had progressed despite treatment with Roche and Biogen Idec’s Rituxan (rituximab) or conventional chemotherapy. Idelalisib
3 Reasons to Buy Gilead Sciences, Inc.Motley Fool
Standard Review for Gilead’s Oncology Candidate – Analyst BlogNASDAQ
Gilead’s Idelalisib NDA accepted by US FDA for the treatment of refractory MENAFN.COM

all 14 news articles »